Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo, 162-8601, Japan.
Nat Commun. 2019 Sep 2;10(1):3925. doi: 10.1038/s41467-019-11760-2.
Mismatch repair (MMR)-deficient cancers are characterized by microsatellite instability (MSI) and hypermutation. However, it remains unclear how MSI and hypermutation arise and contribute to cancer development. Here, we show that MSI and hypermutation are triggered by replication stress in an MMR-deficient background, enabling clonal expansion of cells harboring ARF/p53-module mutations and cells that are resistant to the anti-cancer drug camptothecin. While replication stress-associated DNA double-strand breaks (DSBs) caused chromosomal instability (CIN) in an MMR-proficient background, they induced MSI with concomitant suppression of CIN via a PARP-mediated repair pathway in an MMR-deficient background. This was associated with the induction of mutations, including cancer-driver mutations in the ARF/p53 module, via chromosomal deletions and base substitutions. Immortalization of MMR-deficient mouse embryonic fibroblasts (MEFs) in association with ARF/p53-module mutations was ~60-fold more efficient than that of wild-type MEFs. Thus, replication stress-triggered MSI and hypermutation efficiently lead to clonal expansion of cells with abrogated defense systems.
错配修复(MMR)缺陷型癌症的特征是微卫星不稳定(MSI)和超突变。然而,MSI 和超突变如何产生以及如何促进癌症发展仍不清楚。在这里,我们表明,在 MMR 缺陷型背景下,复制应激会引发 MSI 和超突变,从而使 ARF/p53 模块突变的细胞和对抗癌药物喜树碱有抗性的细胞能够克隆性扩张。虽然与复制应激相关的 DNA 双链断裂(DSBs)在 MMR 功能正常的背景下会导致染色体不稳定性(CIN),但在 MMR 缺陷型背景下,它们通过 PARP 介导的修复途径诱导 MSI,同时抑制 CIN。这与通过染色体缺失和碱基替换诱导突变有关,包括 ARF/p53 模块中的癌症驱动突变。与野生型 MEFs 相比,与 ARF/p53 模块突变相关的 MMR 缺陷型小鼠胚胎成纤维细胞(MEFs)的永生化效率约高 60 倍。因此,复制应激引发的 MSI 和超突变有效地导致了防御系统被破坏的细胞的克隆性扩张。